PMC:7195088 / 11053-11345 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"173","span":{"begin":218,"end":226},"obj":"Species"}],"attributes":[{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"dulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent patients, which, although promising in small case series, both deserve ded"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":174,"end":189},"obj":"Body_part"},{"id":"T4","span":{"begin":193,"end":199},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"dulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent patients, which, although promising in small case series, both deserve ded"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T39","span":{"begin":193,"end":199},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"dulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent patients, which, although promising in small case series, both deserve ded"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":55,"end":72},"obj":"Chemical"},{"id":"T49","span":{"begin":62,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_23924"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"dulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent patients, which, although promising in small case series, both deserve ded"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":128,"end":143},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"dulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent patients, which, although promising in small case series, both deserve ded"}